首页> 外文期刊>The journal of clinical endocrinology and metabolism >An Open-Label, Prospective Pilot Clinical Study of Denosumab for Severe Hyperparathyroidism in Patients With Low Bone Mass Undergoing Dialysis
【24h】

An Open-Label, Prospective Pilot Clinical Study of Denosumab for Severe Hyperparathyroidism in Patients With Low Bone Mass Undergoing Dialysis

机译:地诺单抗用于接受透析的低骨量患者严重甲状旁腺功能亢进的开放标签,前瞻性临床研究

获取原文
       

摘要

Context:Denosumab is widely used for bone diseases with increased bone resorption. Its effectiveness in patients with severe secondary hyperparathyroidism on dialysis is unclear.
机译:背景:Denosumab被广泛用于骨骼吸收增加的骨骼疾病。目前尚不清楚其对严重继发性甲状旁腺功能亢进症透析患者的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号